Price Performance
- Day's Low
- ₹944.5
- Day's High
- ₹958.65
₹ 947.4
- 52-w low
- ₹484.95
- 52-w high
- ₹1,031.70
947.4
- Day's open
₹951.5 - Previous close
₹951.25 - VWAP
₹949.91 - Lower price band
₹852.7 - Upper price band
₹1,042.10
Today's Market Action
The last traded share price of Zydus Lifesciences Ltd was 947.40 down by -0.40% on the NSE. Its last traded stock price on BSE was 947.90 down by -0.32%. The total volume of shares on NSE and BSE combined was 697,528 shares. Its total combined turnover was Rs 66.26 crores.
Medium and Long Term Market Action
Zydus Lifesciences Ltd hit a 52-week high of 1,031.70 on 01-04-2024 and a 52-week low of 484.95 on 22-05-2023.
The stock price of Zydus Lifesciences Ltd is down by -5% over the last one month. It is up by 83.87% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 95331
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Zydus Lifesciences Ltd?
What is the Market Cap of Zydus Lifesciences Ltd?
What is PE Ratio of Zydus Lifesciences Ltd?
What is PB Ratio of Zydus Lifesciences Ltd?
What is the CAGR of Zydus Lifesciences Ltd?
How to Buy Zydus Lifesciences Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Momentum Strength
Above Average Sustainable RoE
Great Cash Conversion of Profits
High Pricing Power
Zero Debt
Above Average Growth Rate
Cons
Capital Intensive Business
Poor Working Capital Cycle
Negative Margin of Safety
Valuation Analysis
Margin of safety
(27/04/2024)
(27/04/2024)
85
86.36%
86.36% People are bullish about Zydus Lifesciences Ltd
13.64%
13.64 % People are bearish about Zydus Lifesciences Ltd